News
-
-
PRESS RELEASE
PolyPeptide Group: Samsung Biologics announces tender offer to acquire PolyPeptide Group AG for CHF 44.31 per share
Samsung Biologics announces tender offer to acquire PolyPeptide Group AG at CHF 44.31 per share, reflecting growth and profitability. PolyPeptide reports marked acceleration in H1 2026 results -
-
-
-
-
-
-
-